Just realized that there is a phase 2b to the Parkinson Disease CRE 120 trials still ongoing. Therefore if this is the target of their acquisition Phase III may not start until 2013 or 2014
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.